Gara Jalqabaatti › Hemoglobinopathies
Qorannoo klinikaalii Hemoglobinopathies Ameerikaa Keessatti hirmaatuu
Qorannoo 14 Hemoglobinopathies f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- St. Louis, MOQorannoo 4
- New York City, NYQorannoo 4
- Philadelphia, PAQorannoo 3
- Minneapolis, MNQorannoo 3
- Nashville, TNQorannoo 3
- Memphis, TNQorannoo 3
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06313398Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 20 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT00920972Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06646640The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07227155Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Namoota walitti qabaa jira
Hanga umuriin 55 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01666080TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 0 hanga 21 · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT04356469Allo HSCT for High Risk Hemoglobinopathies
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Hanga umuriin 55 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06872333Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Namoota walitti qabaa jiraSadarkaa 1/2
1 Day – 21 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT03128996Discarded Bone Marrow for Hematology Research
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT04671212Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Namoota walitti qabaa jiraSadarkaa 1/2
1 Month – 25 Years · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06839456Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 35 · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT05477563Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 21 · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT04644016A Long-term Follow-up Study in Patients Who Received BEAM-101
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 14 hanga 37 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07373639Study of the Role of Genetic Modifiers in Hemoglobinopathies
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 20-Bit-2024 · NCT05799118Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.